Proper Nutrition, Physical Exercise and Appropriate Weight in Individuals With Long Term Mental Illness

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00474227

Enrollment

Registered

2007-05-16

Start date

2007-04-30

Completion date

2007-10-31

Last updated

2008-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Keywords

obesity, weight gain, schizophrenia, schizoaffective disorder, antipsychotic induced weight gain

Brief summary

Based on previous findings that mentally ill inpatients are interested in losing treatment associate weight gain and are capable of adhering to a weight reduction program, this study will investigate the effects of participation in nutrition intervention, physical exercise and will monitor measurement of metabolic profiles (cholesterol, triglycerides and glucose). Hypothesis: participants will reduce weight, maintain weight loss and experience reduction in metabolic values and will experience improved quality of life.

Detailed description

Study sample: 50 chronic psychiatric inpatients with DSM\_IV diagnosis of schizophrenia or schizoaffective disorder, aged 18 or older. Exclusion criteria - pregnancy, severe physical illness, refusal to participate. Study instruments: Q-LES-Q-18 (quality of life): Positive and Negative Syndrome Scale; Laboratory test- glucose levels, metabolic profiles (cholesterol, triglycerides). Measurements: Weight, BMI, pulse Intervention: Weekly group therapy, lectures on nutrition, physical exercise Duration of study: 3 months

Interventions

BEHAVIORALgroup therapy, physical exercise, nutrition lectures

weekly group therapy, physical exercize, nutrition guidance

Study design

Allocation

NON_RANDOMIZED

Intervention model

PARALLEL

Primary purpose

BASIC_SCIENCE

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 70 Years

Healthy volunteers

Inclusion criteria

* Ages 18 and older * Men or women * Schizophrenia or schizoaffective disorder * BMI greater than 26 * Agreement to participate and capacity to provide written informed consent

Exclusion criteria

* Pregnancy * Severe physical illness * Refusal to participate

Design outcomes

Primary

Measure	Time frame
weight reduction	three months

Secondary

Measure	Time frame
improved metabolic profile	3 months

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026